benzinga95d ago
Retail investors talked up five hot stocks this week (March 9 to March 13) on X and Reddit's r/WallStreetBets, driven by retail hype, earnings, AI buzz, and corporate news flow.Oracle Corp. (NYSE:ORCL), Hims & Hers Health Inc. (NYSE:HIMS), Blue Owl Capital Inc. (NYSE:OWL), Strategy Inc. (NASDAQ:MSTR), Tesla Inc. (NASDAQ:TSLA), spanning software, online retail, pharma, private credit, cryptocurrency, and automotive, reflected diverse investor interests.OracleORCL’s fiscal third-quarter earnings delivered strong beats with total revenue of $17.2 billion up 22% YoY, cloud revenue surging 44% to $8.9 billion, non-GAAP EPS of $1.79, up 21%, and remaining performance obligations exploding 325% to $553 billion, driven by massive AI infrastructure demand. The company raised its fiscal 2027 revenue guidance to $90 billion, easing concerns over heavy AI capex and debt. Some retail investors were questioning other traders about buying ORCL after its post-earnings jump.Source: RedditThe stock had a 52-week range of $118.86 to $345.72, trading around $159 to $162 per share, as of the publication of this article. It rose 5.48% over the year and fell 45.53% over the last six months.ORCL had a weaker price trend in the short, medium, and long term, with a poor value ranking, as per Benzinga's Edge Stock Rankings. Hims & HersHIMS news stories from March 9 to March 13, 2026, were dominated by the company’s blockbuster partnership announcement with Novo Nordisk A/S (NYSE:NVO), which sent the stock soaring. Under the deal, Hims & Hers will offer Novo Nordisk’s branded GLP-1 weight-loss drugs like Ozempic and Wegovy on its telehealth platform starting later in March, while ceasing promotion of compounded versions—resolving a prior patent infringement lawsuit from Novo and eliminating a ...Full story available on Benzinga.com
